Deciphera Pharmaceuticals Inc (DCPH.OQ)
DCPH.OQ on NASDAQ Stock Exchange Global Select Market
29.00USD
15 Feb 2019
29.00USD
15 Feb 2019
Change (% chg)
$1.03 (+3.68%)
$1.03 (+3.68%)
Prev Close
$27.97
$27.97
Open
$28.06
$28.06
Day's High
$29.03
$29.03
Day's Low
$27.72
$27.72
Volume
48,104
48,104
Avg. Vol
88,864
88,864
52-wk High
$45.61
$45.61
52-wk Low
$18.56
$18.56
Revenue & Earnings Per Share
Revenue* | Earnings Per Share** | ||
---|---|---|---|
FY 2018 | Sep '18 | 0.00 | -0.649 |
Jun '18 | 0.00 | -0.646 | |
Mar '18 | 0.00 | -0.657 | |
FY 2017 | Dec '17 | 0.00 | -0.649 |
Sep '17 | 0.00 | -0.392 | |
Jun '17 | 0.00 | -0.346 | |
Mar '17 | 0.00 | -0.251 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
# of Estimates | Mean | High | Low | 1 Year Ago | |
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Mar-19 | 6 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Jun-19 | 6 | 0.00 | 0.00 | 0.00 | 0.00 |
Year Ending Dec-19 | 10 | 10.00 | 100.00 | 0.00 | 18.75 |
Earnings (per share) | |||||
Quarter Ending Mar-19 | 4 | -0.80 | -0.70 | -0.87 | -0.61 |
Quarter Ending Jun-19 | 4 | -0.84 | -0.76 | -0.92 | -0.63 |
Year Ending Dec-19 | 10 | -2.90 | -0.29 | -3.67 | -2.48 |
LT Growth Rate (%) | 1 | 21.00 | 21.00 | 21.00 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
Company | industry | sector | ||
---|---|---|---|---|
P/E Ratio (TTM) | -- | 69.44 | 33.70 | |
P/E High - Last 5 Yrs. | -- | 147.79 | 49.87 | |
P/E Low - Last 5 Yrs. | -- | 47.97 | 24.25 | |
Beta | -- | 1.08 | 0.90 | |
Price to Sales (TTM) | -- | 49.51 | 6.29 | |
Price to Book (MRQ) | -- | 10.14 | 5.26 | |
Price to Tangible Book (MRQ) | 8.04 | 13.78 | 6.77 | |
Price to Cash Flow (TTM) | -- | 56.20 | 24.98 | |
% Owned Institutions | -- | 3.74 | 1.69 |
Dividends
Company | industry | sector | ||
---|---|---|---|---|
Dividend Yield | -- | 0.12 | 1.40 | |
Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
Dividend 5 Year Growth Rate | -- | 0.79 | 4.85 | |
Payout Ratio(TTM) | -- | 7.02 | 41.03 |
Growth Rates
Company | industry | sector | ||
---|---|---|---|---|
Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 205.92 | 12.75 | |
Sales (TTM) vs TTM 1 Yr. Ago | -- | 48.79 | 5.84 | |
Sales - 5 Yr. Growth Rate | -- | 22.76 | 11.23 | |
EPS (MRQ) vs Qtr. 1 Yr. Ago | -79.11 | 75.85 | 47.15 | |
EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
EPS - 5 Yr. Growth Rate | -- | 11.98 | 10.85 | |
Capital Spending - 5 Yr. Growth Rate | -- | 9.07 | 15.20 |
Financial Strength
Company | industry | sector | |
---|---|---|---|
Quick Ratio (MRQ) | -- | 2.24 | 2.25 |
Current Ratio (MRQ) | 11.53 | 3.50 | 3.08 |
LT Debt to Equity (MRQ) | 1.59 | 18.65 | 11.38 |
Total Debt to Equity (MRQ) | 1.80 | 31.33 | 16.12 |
Interest Coverage (TTM) | -- | -43.11 | 29.47 |
Profitability Ratios
Company | industry | sector | ||
---|---|---|---|---|
Gross Margin (TTM) | -- | 56.24 | 53.81 | |
Gross Margin - 5 Yr. Avg. | -- | 60.48 | 52.18 | |
EBITD Margin (TTM) | -- | -- | -- | |
EBITD - 5 Yr. Avg | -- | -110.45 | 12.86 | |
Operating Margin (TTM) | -- | -184.67 | 6.20 | |
Operating Margin - 5 Yr. Avg. | -- | -126.94 | 8.31 | |
Pre-Tax Margin (TTM) | -- | -175.36 | 7.16 | |
Pre-Tax Margin - 5 Yr. Avg. | -- | -132.73 | 8.61 | |
Net Profit Margin (TTM) | -- | -182.07 | 3.29 | |
Net Profit Margin - 5 Yr. Avg. | -- | -137.12 | 4.89 | |
Effective Tax Rate (TTM) | -- | 22.48 | 22.91 | |
Effective Tax Rate - 5 Yr. Avg. | -- | 15.51 | 23.38 |
Efficiency
Company | industry | sector | ||
---|---|---|---|---|
Revenue/Employee (TTM) | -- | 7,654,354 | 842,397,297 | |
Net Income/Employee (TTM) | -- | 562,076 | 99,842,671 | |
Receivable Turnover (TTM) | -- | 6.23 | 5.71 | |
Inventory Turnover (TTM) | -- | 1.89 | 3.47 | |
Asset Turnover (TTM) | -- | 0.32 | 0.93 |
Management Effectiveness
Company | industry | sector | ||
---|---|---|---|---|
Return on Assets (TTM) | -- | 6.39 | 11.06 | |
Return on Assets - 5 Yr. Avg. | -- | 5.47 | 12.20 | |
Return on Investment (TTM) | -- | 8.92 | 14.45 | |
Return on Investment - 5 Yr. Avg. | -- | 6.78 | 15.87 | |
Return on Equity (TTM) | -- | 10.08 | 15.96 | |
Return on Equity - 5 Yr. Avg. | -- | 8.32 | 17.00 |
1 Year | 3 Year | 5 Year | |
---|---|---|---|
Sales % | -- | -- | -- |
EPS (TTM) % | -30.90 | -- | -- |
Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Deciphera Pharmaceuticals Inc
Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
---|---|---|---|---|
4 Week | -- | -- | -- | 99 |
13 Week | -- | -- | -- | 95 |
26 Week | -- | -- | -- | 98 |
52 Week | -- | -- | -- | 72 |
YTD | -- | -- | -- | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
% Shares Owned: | 58.57% |
# of Holders: | 113 |
Total Shares Held: | 22,059,929 |
3 Mo. Net Change: | 935,332 |
# New Positions: | 18 |
# Closed Positions: | 28 |
# Increased Positions: | 61 |
# Reduced Positions: | 50 |
# Net Buyers: | 11 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.